eCancer Oct 21 2025 New research reveals that the number and complexity of cancer clinical trials since 2001 have varied across low- and middle-income countries (LMICs), with economic growth contributing to disparities, but only to a certain extent. The findings are published by Wiley online in CANCER , a peer-reviewed journal of the American Cancer Society. Although LMICs are expected to experience the greatest global burden of cancer in the coming years, cancer clinical trials are